A modified LC-MS/MS method for the detection of whole blood tacrolimus and its clinical value in Chinese kidney transplant patients
2022 · Heliyon · 9 citations
https://doi.org/10.1016/j.heliyon.2022.e10214
B
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
72
Citations
5
h-index
3
i10-index
Beibei Zhao is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Amyloidosis: Diagnosis, Treatment, Outcomes & Metabolomics and Mass Spectrometry Studies & Renal function and acid-base balance. The author has an h-index of 5, co-authored 17 publications.
ORCID: 0000-0001-8514-3358Papers by this author
worksChina nationwide landscape of 16 types inherited metabolic disorders: a retrospective analysis on 372,255 clinical cases
2023 · Orphanet Journal of Rare Diseases · 3 citations
https://doi.org/10.1186/s13023-023-02834-y
Additional file 6 of A stepwise data interpretation process for renal amyloidosis typing by LMD-MS
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19593947
Additional file 4 of A stepwise data interpretation process for renal amyloidosis typing by LMD-MS
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19593941
Additional file 5 of A stepwise data interpretation process for renal amyloidosis typing by LMD-MS
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19593944
Additional file 3 of A stepwise data interpretation process for renal amyloidosis typing by LMD-MS
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19593938
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat